Finance

Lists
Q3 2026 earnings • released • Revenue miss -२.५३%
See results
ALM:BME
Almirall SA
€ १०.५०
-६.४२%
(-०.७२) 1D
नोभेम्बर ९, १७:३८:४० GMT+१  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ALM...
Open
€ ११.४४
High
€ ११.६४
Low
€ १०.४२
Mkt. cap
२.२९ अरब
Avg. vol.
१.१० लाख
Volume
६.२१ लाख
Dividend
१.७८%
Quarterly dividend
€ ०.०५
Ex-dividend date
२०१७ मे ३०
P/E ratio
३८.९१
52-wk high
€ १३.९८
52-wk low
€ ९.८१
EPS
€ ०.२७
Shares outstanding
२१.७८ करोड
No. of employees
२ हजार
Open
€ ११.४४
High
€ ११.६४
Low
€ १०.४२
Mkt. cap
२.२९ अरब
Avg. vol.
१.१० लाख
Volume
६.२१ लाख
Dividend
१.७८%
Quarterly dividend
€ ०.०५
Ex-dividend date
२०१७ मे ३०
P/E ratio
३८.९१
52-wk high
€ १३.९८
52-wk low
€ ९.८१
EPS
€ ०.२७
Shares outstanding
२१.७८ करोड
No. of employees
२ हजार
News stories
From web sources and news partners
Investing.com
Investing.com
·
२० घण्टा पहिले
Almirall Q3 2026 slides: biologics drive growth despite earnings miss
Investing.com
Investing.com
·
२० घण्टा पहिले
Almirall shares drop 2% after nine-month sales miss estimates
Investing.com
Investing.com
·
२० घण्टा पहिले
Earnings call transcript: Almirall misses Q3 2026 profit view as sales rise
Profile
Almirall, S.A. is a Spanish pharmaceutical company dedicated to medical dermatology, with headquarters in Barcelona, founded in 1944. In 2023, the company generated total revenues of €898.8 million and was the leading European company in medical dermatology. With approximately 1,904 employees, it has a direct presence in 20 countries through its 15 subsidiaries in Europe and the USA. Wikipedia
About Almirall SA
CEOCarlos Gallardo Piqué | Gianfranco Nazzi
Employees२.१ हजार
Founded१९४४
Headquarters-
SectorHealth Care
Industry-
Last report
२०२६ नोभेम्बर ९
Fiscal period
Q3 2026
- / € ०.०८
Revenue / Est. (EUR)
२८.६५ करोड / २९.३९ करोड
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
२६.२२ करोड
२८.८९ करोड
२९.२४ करोड
३१.३२ करोड
Cost of goods sold
१५.७७ करोड
-२.७७ करोड
१०.४३ करोड
३.१३ करोड
Cost of revenue
१५.७७ करोड
-२.७७ करोड
१०.४३ करोड
३.१३ करोड
Research and development expenses
१०.२४ करोड
-१०.२४ करोड
३.४८ करोड
-३.४८ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२३.५० करोड
-१०.२९ करोड
१२.१६ करोड
१.४९ करोड
Operating expense
८.१३ करोड
३१.०९ करोड
१५.८१ करोड
२४.०२ करोड
Total operating expenses
२३.९१ करोड
२८.३२ करोड
२६.२४ करोड
२७.१४ करोड
Operating income
२.३२ करोड
५६.८६ लाख
३.०० करोड
४.१८ करोड
Other non operating income
२१.६१ लाख
३३.६२ लाख
-१७.०० लाख
-२२.६७ लाख
EBT including unusual items
२.१० करोड
९३.४८ लाख
२.३४ करोड
३.७५ करोड
EBT excluding unusual items
२.३४ करोड
५७.८३ लाख
२.४५ करोड
३.६५ करोड
Income tax expense
८४.५३ लाख
२२.९४ लाख
८१.०० लाख
१.३२ करोड
Effective tax rate
४०.३०%
२४.५४%
३४.६२%
३५.२४%
Other operating expenses
-१७.९७ करोड
३६.५० करोड
१७.०० लाख
१८.४८ करोड
Net income
१.२५ करोड
७०.५४ लाख
१.५३ करोड
२.४३ करोड
Net profit margin
४.७७%
२.४४%
५.२३%
७.७४%
Earnings per share
-
-
-
-
Interest and investment income
१३.६६ लाख
१३.४८ लाख
१०.०० लाख
१५.३८ लाख
Interest expense
-३८.९० लाख
-५०.४८ लाख
-४५.०० लाख
-४६.२० लाख
Net interest expenses
-२५.२४ लाख
-३७.०० लाख
-३५.०० लाख
-३०.८२ लाख
Depreciation and amortization charges
-७.६४ करोड
१५.१२ करोड
-
७.५३ करोड
EBITDA
६.९७ करोड
२.३७ करोड
६.७५ करोड
६.९१ करोड
Gain or loss from assets sale
-
१.९९ लाख
-
१.१४ लाख
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू